<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526383</url>
  </required_header>
  <id_info>
    <org_study_id>P060219</org_study_id>
    <nct_id>NCT00526383</nct_id>
  </id_info>
  <brief_title>Do Antidepressants Induce Metabolic Syndromes METADAP Study</brief_title>
  <acronym>METADAP</acronym>
  <official_title>Do Antidepressants Induce Metabolic Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1
      antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes
      is a matter of concern.

      The main objective of this study is to assess the differential impact of antidepressants in
      terms of weight gain and metabolic syndromes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1
      antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes
      is a matter of concern.

      The main objective of this study is to assess the differential impact of antidepressants in
      terms of weight gain and metabolic syndromes.

      Prospective 6-month naturalistic cohort study, comparing 4 classes of antidepressants (SSRIs,
      SNRIs, TCAs and others) to a control group (ECT and r-TMS), in 600 patients with a major
      depressive disorder requiring the beginning of either antidepressant or ECT/r-TMS treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Definition criteria of the metabolic syndromes: Weight and waist circumference Systolic and diastolic blood pressure Glycemia Triglyceridemia Cholesterolemia Insulinemia</measure>
    <time_frame>at Months 0, 1, 3, 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Antidepressant efficacy (HAM-D, quickIDS-C, quickIDS-SR, CGI)</measure>
    <time_frame>at Months 0, 1, 3, 6</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">624</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>antidepressant versus medical dispositive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tricyclic antidepressants</intervention_name>
    <description>antidepressant version medical dispositive</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <other_name>antidepressant version medical dispositive</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age : 18-70

          -  Current major depressive episode (Major depressive disorder) based on the MINI
             interview

          -  HAM-D &gt;18

          -  Requiring either antidepressant treatment, either ECT or r-TMS (as assessed by the
             clinician)

          -  Signed informed consent

        Exclusion Criteria:

          -  Bipolar disorder (DSM-IV), Psychotic disorder (DSM-IV), Substance abuse or dependence
             (DSM-IV)

          -  Normothymic treatment

          -  Antipsychotic treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuelle CORRUBLE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique hopital Bicêtre</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>April 16, 2014</last_update_submitted>
  <last_update_submitted_qc>April 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Major depressive disorder</keyword>
  <keyword>Antidepressants</keyword>
  <keyword>Weight gain</keyword>
  <keyword>Metabolic syndromes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Antidepressive Agents, Tricyclic</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

